GMP Update: Reducing Obstacles to Innovation

Pharmaceutical Technology, Pharmaceutical Technology-10-02-2003, Volume 27, Issue 10

FDA offers new policies to encourage modern manufacturing approaches and automated systems, to simplify postapproval changes, and to avoid problems with sterile products.

Related Content:

Regulatory/GMP ComplianceRegulatory WatchPharmaceutical Technology-10-02-2003
Biologic Standards in the Pharmacopoeias: An Update
Advancing Global Collaboration for Drug Testing, Regulation, and Manufacturing
Regulatory Compliance Versus Real Compliance